Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Central Nervous System Neoplasms × vitespin × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Sarcoma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Radiotherapy 49 Temozolomide 44 Cyclophosphamide 21 Filgrastim 20 Etoposide 20 Carboplatin 18 Chemotherapy, Adjuvant 16 Vincristine 15 Cisplatin 15 Peripheral Blood Stem Cell Transplantation 13 Thiotepa 11 Carmustine 11 Thalidomide 10 Magnetic Resonance Spectroscopy 9 Bevacizumab 9 Irinotecan 8 Methotrexate 7 sargramostim 6 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Lomustine 5 Granulocyte Colony-Stimulating Factor 5 Celecoxib 5 Topotecan 4 Tamoxifen 4 Surgical Procedures, Operative 4 Procarbazine 4 Nuclear Medicine Department, Hospital 4 Erlotinib Hydrochloride 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00905060 2021-03-24

HeatShock

University of California, San Francisco

Phase 2 Completed

70 enrolled 12 charts

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡